Value-Based Pricing Impact is a budget impact consideration that quantifies the financial effect of adopting a health intervention based on its demonstrated clinical outcomes and patient benefits relative to its cost, distinguishing it from traditional pricing models by aligning price with the value delivered in real-world healthcare settings.
96
Publications
4.7K
Citations
252
Authors
139
Institutions
Publications per year
2017–2026
45
Parents
Publications
96
Value based pricing for NHS drugs: an opportunity not to be missed?
Karl Claxton, Andrew Briggs, Martin Buxton et al. · BMJ · 2008 · 232 citations · Full text
1–5 of 96
Authors
252
- AT
4
h-index
- SM
4
h-index
- AH
3
h-index
- PM
3
h-index
- KC
3
h-index
1–5 of 252
Institutions
139
Case Western Reserve University
Cleveland, United States
4 h-index
8 publications
319 citations
University of Pennsylvania
Philadelphia, United States
4 h-index
6 publications
416 citations
Harvard University
Cambridge, United States
4 h-index
10 publications
773 citations
University of York
York, United Kingdom
4 h-index
12 publications
964 citations
Office Of Health Economics
London, United Kingdom
4 h-index
9 publications
788 citations
Utrecht University
Utrecht, The Netherlands
3 h-index
6 publications
106 citations
Brigham and Women's Hospital
Boston, United States
3 h-index
6 publications
350 citations
University of Verona
Verona, Italy
3 h-index
3 publications
50 citations
1–8 of 139
Venues
- Health Economics
7 publications · 530 citations
7
h-index
- Industrial Marketing Management
5 publications · 725 citations
5
h-index
- Value in Health
4 publications · 164 citations
4
h-index
- Journal of Business Research
JBR · 4 publications · 214 citations
4
h-index
- JAMA
3 publications · 153 citations
3
h-index
1–5